Table 4.
Outcome measure | Baseline | Follow-up | Agreement | Difference | Mdiff | SD | 90% CI |
---|---|---|---|---|---|---|---|
List A Trial 1 | 8.73 (2.86) | 9.35 (3.11) | r = .63, p < .001 | t = 2.21, p = .03 | 0.62 | 2.59 | −3.64, 3.21 |
List A Trial 2 | 12.8 (3.05) | 13.29 (3.47) | r = .62, p < .001 | t = 1.57, p = .12 | 0.49 | 2.88 | −4.25, 5.23 |
List A Trial 3 | 15.38 (2.93) | 15.04 (3.13) | r = .55, p < .001 | t = 1.16, p = .25 | −0.35 | 2.79 | −4.94, 4.24 |
Total Learning List A (Trials 1 to 3) | 36.92 (8.05) | 37.67 (8.87) | r = .69, p < .001 | t = 1.05, p = .30 | 0.76 | 6.68 | −10.23, 7.44 |
List B | 8.02 (3.32) | 8.12 (3.48) | r = .60, p < .001 | t = 0.28, p = .78 | .093 | 3.04 | −4.91, 5.09 |
SDFR List A | 12.56 (3.76) | 12.37 (3.59) | r = .57, p < .001 | t = 0.44, p = .66 | −0.19 | 3.95 | −6.69, 6.31 |
LDFR List A | 11.58 (4.14) | 11.64 (4.69) | r = .65, p < 0.001 | t = 0.15, p = .89 | 0.06 | 3.71 | −6.04, 6.16 |
LDFR List B | 3.59 (3.65) | 3.48 (3.75) | r = .60, p < .001 | t = 0.32, p = .075 | −0.12 | 3.33 | −5.60, 5.36 |
Recognition Hits | 17.07 (2.73) | 17.3 (2.48) | r = .64, p < .001 | t = 0.98, p = .33 | 0.23 | 2.21 | −3.41, 3.87 |
Recognition False Positives | 2.77 (3.79) | 2.74 (3.85) | r = .56, p < .001 | t = 0.06, p = .95 | −0.02 | 3.59 | −5.93, 5.70 |
Source—A | 16.93 (2.89) | 17.07 (2.61) | r = .53, p < .001 | t = 0.48, p = .63 | 0.14 | 2.69 | −4.29, 4.57 |
Source—B | 17.72 (2.97) | 18.23 (2.4) | r = .49, p < .001 | t = 1.72, p = .89 | 0.51 | 2.76 | −4.03, 5.05 |
Note. Pearson correlations are used to show the degree of agreement across testing sessions and within-participant t tests are used to show degree of difference. The mean difference (Mdiff; follow-up − baseline performance) score and standard deviation (SD) of the mean difference scores are used to generate 90% confidence interval (CI) scores, which can be used to generate RCIs. Test–retest reliability statistics for baseline and follow-up. Forms 1 and 2 were combined, administered an equal number of times within each session, and counterbalanced.